Discontinued — last reported Q4 '25
Johnson & Johnson Deferred Taxes increased by 168.8% to $2.22B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 2364.4%, from $90.00M to $2.22B.
A large deferred tax benefit (negative value) may signal future cash outflows, while a deferred tax expense (positive value) suggests cash savings today.
The difference between the income tax expense reported on the financial statements and the actual taxes paid to authorit...
Multinational corporations often have complex deferred tax profiles due to varying international tax jurisdictions.
cf_deferred_income_taxes| Q2 '21 | Q2 '22 | Q2 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$730.00M | -$926.00M | -$1.54B | -$1.56B | -$695.00M | $90.00M | -$16.00M | $2.17B | $825.00M | $2.22B |
| QoQ Change | — | -26.8% | -66.6% | -1.2% | +55.5% | +112.9% | -117.8% | >999% | -62.0% | +168.8% |
| YoY Change | — | -26.8% | -66.6% | — | +55.0% | — | — | +239.1% | +218.7% | >999% |
We use cookies for analytics. See our Privacy and Cookie Policy.